Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic
Mattocks KM, Moore DT, Wischik DL, Lazar CM, Rosen MI. Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic. Journal Of Substance Use And Addiction Treatment 2022, 139: 108777. PMID: 35346533, PMCID: PMC8949846, DOI: 10.1016/j.jsat.2022.108777.Peer-Reviewed Original ResearchConceptsOpioid use disorderVeterans Health AffairsVA Medical CenterTreatment of OUDVirtual visitsSerious public health issueOpioid addiction epidemicUse of telemedicineCOVID-19Public health issuePotential study participantsHarm reduction approachPatient's autonomous decisionBuprenorphine treatmentOUD treatmentChronic painCOVID-19 transmissionOUD careVA providersVA cliniciansMedical CenterOpioid addictionVHA providersUse disordersAddiction epidemic